Key points from article :
Neurolutions won FDA de novo authorization to introduce its IpsiHand stroke rehab system in the United States.
This is the first approval of a brain-computer interface technology for the rehabilitation of stroke patients.
Indicated for use in patients 18 and older undergoing stroke rehabilitation.
It promises a faster and complete recovery of hand function.
Takes advantage of the uninjured side of the brain to trigger a robotic exoskeleton placed over the affected arm.
Patient wears a brain-wave detecting EEG headset that interprets and sends signals to the exoskeleton.
“Neurons that fire together wire together,” - Neurolutions.
As the patient desires to move the hand, it actually does.
Performed repeatedly during multiple sessions at the clinic or independently at home.
Improve therapy outcomes, including muscle re-education and increased range of motion, long after (≥ 6 months) stroke diagnosis.
Adverse events reported included minor fatigue, discomfort, and temporary skin redness.
